A20 inactivating mutations exclusively in EBV− HL cases seem to replace the transforming and NF-κB-activating role of LMP1 in EBV+ HL cases and demonstrate the essential role of EBV in the pathogenesis of EBV+ HL. Here, PDLIM7 is linked to Hodgkins lymphoma.